Global Hormone Replacement Therapy Market 2014-2018 is a new market research publication announced by Reportstack. Hormone replacement therapy, also known as hormone therapy, is a means of replacing hormones that are no longer being produced by the body. This type of therapy is usually initiated at menopause or may be started while a woman is in the perimenopausal phase, nearing menopause. Hormone replacement therapy replenishes the hormones required by the human body to function by using bio-identical hormones. The therapy contains estrogen and progesterone, and in some cases testosterone, to reduce symptoms of menopause. This replacement therapy may also protect against osteoporosis, reduce the risk of coronary heart disease, and may prevent or delay the onset of Alzheimer's disease. Replacement therapy can also increase the chance of developing more serious health complications such as blood clots, breast cancer, uterine cancer, and bowel cancer.
The analysts forecast that the Global Hormone Replacement Therapy market will grow at a CAGR of 2.51 percent over the period 2013-2018. The Global Hormone Replacement Therapy market can be divided into three segments: Estrogen Replacement Therapy, Growth Hormone Replacement Therapy, and Thyroid Hormone Replacement Therapy. This report covers the present scenario and the growth prospects of the Global Hormone Replacement Therapy market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of the various hormone replacement therapies that are available in the market.
The report Global Hormone Replacement Therapy Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, EMEA, and APAC regions; it also covers the Global Hormone Replacement Therapy market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key Regions
• Americas
• EMEA
• APAC
Key Vendors
• Actavis plc
• Bayer AG
• Merck & Co. Inc.
• Novartis AG
• Novo Nordisk A/S
Other Prominent Vendors
• Abbott Laboratories Ltd.
• Amgen Inc.
• ANI Pharmaceuticals Inc.
• Hisamitsu Pharmaceutical Co. Inc.
• Mylan Laboratories Inc.
• Orion Corp.
• QuatRx Pharmaceuticals Co.
• Teva Pharmaceutical Industries Ltd.
• TherapeuticsMD Inc.
Key Market Driver
• Significant Unmet Need for Hormone Replacement Therapy
• For a full, detailed list, view our report.
Key Market Challenge
• High Cost of Hormone Replacement Therapy
• For a full, detailed list, view our report.
Key Market Trend
• Paradigm Shift Toward Transdermal Systems
• For a full, detailed list, view our report.
Key Questions Answered in this Report
• What will the market size be in 2018 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
The analysts forecast that the Global Hormone Replacement Therapy market will grow at a CAGR of 2.51 percent over the period 2013-2018. The Global Hormone Replacement Therapy market can be divided into three segments: Estrogen Replacement Therapy, Growth Hormone Replacement Therapy, and Thyroid Hormone Replacement Therapy. This report covers the present scenario and the growth prospects of the Global Hormone Replacement Therapy market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of the various hormone replacement therapies that are available in the market.
The report Global Hormone Replacement Therapy Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, EMEA, and APAC regions; it also covers the Global Hormone Replacement Therapy market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key Regions
• Americas
• EMEA
• APAC
Key Vendors
• Actavis plc
• Bayer AG
• Merck & Co. Inc.
• Novartis AG
• Novo Nordisk A/S
Other Prominent Vendors
• Abbott Laboratories Ltd.
• Amgen Inc.
• ANI Pharmaceuticals Inc.
• Hisamitsu Pharmaceutical Co. Inc.
• Mylan Laboratories Inc.
• Orion Corp.
• QuatRx Pharmaceuticals Co.
• Teva Pharmaceutical Industries Ltd.
• TherapeuticsMD Inc.
Key Market Driver
• Significant Unmet Need for Hormone Replacement Therapy
• For a full, detailed list, view our report.
Key Market Challenge
• High Cost of Hormone Replacement Therapy
• For a full, detailed list, view our report.
Key Market Trend
• Paradigm Shift Toward Transdermal Systems
• For a full, detailed list, view our report.
Key Questions Answered in this Report
• What will the market size be in 2018 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
To view the table of contents and know more details please visit Global Hormone Replacement Therapy Market 2014-2018.
No comments:
Post a Comment